| Views | |
|---|---|
| A distinctive bullous skin reaction associated with enfortumab vedotin‐ejfv treatment for metastatic urothelial cancer: A case report | 123 |
| July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | |
|---|---|---|---|---|---|---|---|
| A distinctive bullous skin reaction associated with enfortumab vedotin‐ejfv treatment for metastatic urothelial cancer: A case report | 13 | 1 | 1 | 27 | 8 | 3 | 3 |
| Views | |
|---|---|
| 2021_Krause_etal.pdf | 237 |
